![IJMS | Free Full-Text | Decreased Expression of ZNF554 in Gliomas is Associated with the Activation of Tumor Pathways and Shorter Patient Survival | HTML IJMS | Free Full-Text | Decreased Expression of ZNF554 in Gliomas is Associated with the Activation of Tumor Pathways and Shorter Patient Survival | HTML](https://www.mdpi.com/ijms/ijms-21-05762/article_deploy/html/images/ijms-21-05762-g004.png)
IJMS | Free Full-Text | Decreased Expression of ZNF554 in Gliomas is Associated with the Activation of Tumor Pathways and Shorter Patient Survival | HTML
![IJMS | Free Full-Text | Decreased Expression of ZNF554 in Gliomas is Associated with the Activation of Tumor Pathways and Shorter Patient Survival | HTML IJMS | Free Full-Text | Decreased Expression of ZNF554 in Gliomas is Associated with the Activation of Tumor Pathways and Shorter Patient Survival | HTML](https://www.mdpi.com/ijms/ijms-21-05762/article_deploy/html/images/ijms-21-05762-g001-550.jpg)
IJMS | Free Full-Text | Decreased Expression of ZNF554 in Gliomas is Associated with the Activation of Tumor Pathways and Shorter Patient Survival | HTML
![Pharmaceutics | Free Full-Text | A Triple Combination of Targeting Ligands Increases the Penetration of Nanoparticles across a Blood-Brain Barrier Culture Model | HTML Pharmaceutics | Free Full-Text | A Triple Combination of Targeting Ligands Increases the Penetration of Nanoparticles across a Blood-Brain Barrier Culture Model | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-00086/article_deploy/html/images/pharmaceutics-14-00086-g006.png)